Submission of Confirmation Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sun Pharma submitted a Confirmation Certificate for the quarter ended 30 September 2025, confirming dematerialisation compliance and listing of securities as per SEBI regulations.
This is a standard regulatory compliance filing and does not contain information that would typically have a significant direct impact on the company's stock price or business operations.
The announcement is a routine compliance filing, indicating adherence to regulatory requirements without presenting any inherently positive or negative financial or operational news.
Sun Pharmaceutical Industries Limited has submitted a Confirmation Certificate dated 06 October 2025 for the quarter ended 30 September 2025. This certificate, received from M/s. MUFG Intime India Pvt. Ltd. (formerly Link Intime India Pvt. Ltd.), the company's Registrar & Share Transfer Agent, confirms the following: * Securities received from depository participants for dematerialisation during the quarter ended 30th September 2025 were confirmed (accepted/rejected) to the depositories. * The securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. * Security certificates received for dematerialisation were mutilated and cancelled after due verification by the depository participant. * The name of the depositories has been substituted in the register of members as the registered owner within the prescribed timelines. * No requests for rematerialisation were received during the quarter.
What to do with a filing like this
Sun Pharmaceutical Industries Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sun Pharmaceutical Industries Limited. Read the original for the full detail.